Cancer Research Prevention Award Metabolism and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 639-644, February 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Izbicka, E.
Right arrow Articles by Von Hoff, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Izbicka, E.
Right arrow Articles by Von Hoff, D. D.
[Cancer Research 59, 639-644, February 1, 1999]
© 1999 American Association for Cancer Research

Experimental Therapeutics

Effects of Cationic Porphyrins as G-Quadruplex Interactive Agents in Human Tumor Cells1

Elzbieta Izbicka2, Richard T. Wheelhouse3, Eric Raymond, Karen K. Davidson, Richard A. Lawrence, Daekyu Sun, Bradford E. Windle, Laurence H. Hurley and Daniel D. Von Hoff

Institute for Drug Development, San Antonio, Texas 78245 [E. I., E. R., D. S., R. A. L., B. E. W., D. D. V. H.]; University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 [K. K. D]; and Drug Dynamics Institute, College of Pharmacy, The University of Texas, Austin, Texas 78712 [R. T. W., L. H. H.]

A series of cationic porphyrins has been identified as G-quadruplex interactive agents (QIAs) that stabilize telomeric G-quadruplex DNA and thereby inhibit human telomerase; 50% inhibition of telomerase activity was achieved in HeLa cell-free extract at porphyrin concentrations in the range <=50 µM. Cytotoxicity of the porphyrins in vitro was assessed in normal human cells (fibroblast and breast) and human tumor cells representing models selected for high telomerase activity and short telomeres (breast carcinoma, prostate, and lymphoma). In general, the cytotoxicity (EC50, effective concentration for 50% inhibition of cell proliferation) against normal and tumor cells was >50 µM. The porphyrins were readily absorbed into tumor cell nuclei in culture. Inhibition of telomerase activity in MCF7 cells by subcytotoxic concentrations of TMPyP4 showed time and concentration dependence at 1–100 µM TMPyP4 over 15 days in culture (10 population doubling times). The inhibition of telomerase activity was paralleled by a cell growth arrest in G2-M. These results suggest that relevant biological effects of porphyrins can be achieved at concentrations that do not have general cytotoxic effects on cells. Moreover, the data support the concept that a rational, structure-based approach is possible to design novel telomere-interactive agents with application to a selective and specific anticancer therapy.




This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
A. Verma, V. K. Yadav, R. Basundra, A. Kumar, and S. Chowdhury
Evidence of genome-wide G4 DNA-mediated gene expression in human cancer cells
Nucleic Acids Res., July 13, 2009; (2009) gkn1076v2.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
N. Kumar, R. Basundra, and S. Maiti
Elevated polyamines induce c-MYC overexpression by perturbing quadruplex-WC duplex equilibrium
Nucleic Acids Res., June 1, 2009; 37(10): 3321 - 3331.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
R. K. Thakur, P. Kumar, K. Halder, A. Verma, A. Kar, J.-L. Parent, R. Basundra, A. Kumar, and S. Chowdhury
Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression
Nucleic Acids Res., January 1, 2009; 37(1): 172 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
N. Kumar and S. Maiti
A thermodynamic overview of naturally occurring intramolecular DNA quadruplexes
Nucleic Acids Res., October 1, 2008; 36(17): 5610 - 5622.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
T. I. Gaynutdinov, R. D. Neumann, and I. G. Panyutin
Structural polymorphism of intramolecular quadruplex of human telomeric DNA: effect of cations, quadruplex-binding drugs and flanking sequences
Nucleic Acids Res., July 1, 2008; 36(12): 4079 - 4087.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Wu, K. Shin-ya, and R. M. Brosh Jr.
FANCJ Helicase Defective in Fanconia Anemia and Breast Cancer Unwinds G-Quadruplex DNA To Defend Genomic Stability
Mol. Cell. Biol., June 15, 2008; 28(12): 4116 - 4128.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
D. J. Patel, A. T. Phan, and V. Kuryavyi
Human telomere, oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics
Nucleic Acids Res., December 3, 2007; 35(22): 7429 - 7455.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
B. Brassart, D. Gomez, A. D. Cian, R. Paterski, A. Montagnac, K.-H. Qui, N. Temime-Smaali, C. Trentesaux, J.-L. Mergny, F. Gueritte, et al.
A New Steroid Derivative Stabilizes G-Quadruplexes and Induces Telomere Uncapping in Human Tumor Cells
Mol. Pharmacol., September 1, 2007; 72(3): 631 - 640.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
Z. G. Fridlender, P. Y. Cohen, O. Golan, N. Arish, S. Wallach-Dayan, and R. Breuer
Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis
Eur. Respir. J., August 1, 2007; 30(2): 205 - 213.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
C. M. Barbieri, A. R. Srinivasan, S. G. Rzuczek, J. E. Rice, E. J. LaVoie, and D. S. Pilch
Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA
Nucleic Acids Res., May 11, 2007; 35(10): 3272 - 3286.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. L. Gill, S. A. Strobel, and J. P. Loria
Crystallization and characterization of the thallium form of the Oxytricha nova G-quadruplex
Nucleic Acids Res., September 11, 2006; 34(16): 4506 - 4514.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Enokizono, Y. Konishi, K. Nagata, K. Ouhashi, S. Uesugi, F. Ishikawa, and M. Katahira
Structure of hnRNP D Complexed with Single-stranded Telomere DNA and Unfolding of the Quadruplex by Heterogeneous Nuclear Ribonucleoprotein D
J. Biol. Chem., May 13, 2005; 280(19): 18862 - 18870.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. Leonetti, S. Amodei, C. D'Angelo, A. Rizzo, B. Benassi, A. Antonelli, R. Elli, M. F. G. Stevens, M. D'Incalci, G. Zupi, et al.
Biological Activity of the G-Quadruplex Ligand RHPS4 (3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) Is Associated with Telomere Capping Alteration
Mol. Pharmacol., November 1, 2004; 66(5): 1138 - 1146.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A. Biroccio and C. Leonetti
Telomerase as a new target for the treatment of hormone-refractory prostate cancer
Endocr. Relat. Cancer, September 1, 2004; 11(3): 407 - 421.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. A. Shammas, R. J. S. Reis, C. Li, H. Koley, L. H. Hurley, K. C. Anderson, and N. C. Munshi
Telomerase Inhibition and Cell Growth Arrest After Telomestatin Treatment in Multiple Myeloma
Clin. Cancer Res., January 15, 2004; 10(2): 770 - 776.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. S. Wang, K. Wu, A. C. Chin, S. Chen-Kiang, K. Pongracz, S. Gryaznov, and M. A. S. Moore
Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma
Blood, January 1, 2004; 103(1): 258 - 266.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. A. Shammas, R. J. Shmookler Reis, M. Akiyama, H. Koley, D. Chauhan, T. Hideshima, R. K. Goyal, L. H. Hurley, K. C. Anderson, and N. C. Munshi
Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma
Mol. Cancer Ther., September 1, 2003; 2(9): 825 - 833.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M.-Y. Kim, M. Gleason-Guzman, E. Izbicka, D. Nishioka, and L. H. Hurley
The Different Biological Effects of Telomestatin and TMPyP4 Can Be Attributed to Their Selectivity for Interaction with Intramolecular or Intermolecular G-Quadruplex Structures
Cancer Res., June 15, 2003; 63(12): 3247 - 3256.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. H. Kim, J. H. Kim, G. E. Lee, J. E. Lee, and I. K. Chung
Potent Inhibition of Human Telomerase by Nitrostyrene Derivatives
Mol. Pharmacol., May 1, 2003; 63(5): 1117 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Redon, S. Bombard, M.-A. Elizondo-Riojas, and J.-C. Chottard
Platinum cross-linking of adenines and guanines on the quadruplex structures of the AG3(T2AG3)3 and (T2AG3)4 human telomere sequences in Na+ and K+ solutions
Nucleic Acids Res., March 15, 2003; 31(6): 1605 - 1613.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
H. Seimiya, T. Oh-hara, T. Suzuki, I. Naasani, T. Shimazaki, K. Tsuchiya, and T. Tsuruo
Telomere Shortening and Growth Inhibition of Human Cancer Cells by Novel Synthetic Telomerase Inhibitors MST-312, MST-295, and MST-199
Mol. Cancer Ther., July 1, 2002; 1(9): 657 - 665.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. L. Grand, H. Han, R. M. Munoz, S. Weitman, D. D. Von Hoff, L. H. Hurley, and D. J. Bearss
The Cationic Porphyrin TMPyP4 Down-Regulates c-MYC and Human Telomerase Reverse Transcriptase Expression and Inhibits Tumor Growth in Vivo
Mol. Cancer Ther., June 1, 2002; 1(8): 565 - 573.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. M. Gowan, J. R. Harrison, L. Patterson, M. Valenti, M. A. Read, S. Neidle, and L. R. Kelland
A G-Quadruplex-Interactive Potent Small-Molecule Inhibitor of Telomerase Exhibiting in Vitro and in Vivo Antitumor Activity
Mol. Pharmacol., May 1, 2002; 61(5): 1154 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson
Natural and pharmacological regulation of telomerase
Nucleic Acids Res., February 15, 2002; 30(4): 839 - 865.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. F. Riou, L. Guittat, P. Mailliet, A. Laoui, E. Renou, O. Petitgenet, F. Megnin-Chanet, C. Helene, and J. L. Mergny
Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands
PNAS, February 14, 2002; (2002) 52698099.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
W. Duan, A. Rangan, H. Vankayalapati, M.-Y. Kim, Q. Zeng, D. Sun, H. Han, O. Yu. Fedoroff, D. Nishioka, S. Y. Rha, et al.
Design and Synthesis of Fluoroquinophenoxazines That Interact with Human Telomeric G-Quadruplexes and Their Biological Effects
Mol. Cancer Ther., December 1, 2001; 1(2): 103 - 120.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. M. Gowan, R. Heald, M. F. G. Stevens, and L. R. Kelland
Potent Inhibition of Telomerase by Small-Molecule Pentacyclic Acridines Capable of Interacting with G-Quadruplexes
Mol. Pharmacol., November 1, 2001; 60(5): 981 - 988.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
A. Adams, J. M. Guss, C. A. Collyer, W. A. Denny, and L. P. G. Wakelin
A novel form of intercalation involving four DNA duplexes in an acridine-4-carboxamide complex of d(CGTACG)2
Nucleic Acids Res., November 1, 2000; 28(21): 4244 - 4253.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Y. Rha, E. Izbicka, R. Lawrence, K. Davidson, D. Sun, M. P. Moyer, G. D. Roodman, L. Hurley, and D. Von Hoff
Effect of Telomere and Telomerase Interactive Agents on Human Tumor and Normal Cell Lines
Clin. Cancer Res., March 1, 2000; 6(3): 987 - 993.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. F. Riou, L. Guittat, P. Mailliet, A. Laoui, E. Renou, O. Petitgenet, F. Megnin-Chanet, C. Helene, and J. L. Mergny
Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands
PNAS, March 5, 2002; 99(5): 2672 - 2677.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Bennett, A. Krah, F. Wien, E. Garman, R. Mckenna, M. Sanderson, and S. Neidle
A DNA-porphyrin minor-groove complex at atomic resolution: The structural consequences of porphyrin ruffling
PNAS, August 15, 2000; 97(17): 9476 - 9481.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.